Controversies in Neurosurgery is made possible by the support of our sponsors

Our major sponsor

Brainlab develops, manufactures and markets software-driven medical technology, enabling access to advanced, less invasive patient treatments.

Brainlab technology powers treatments in radiosurgery as well as numerous surgical fields including neurosurgery, orthopedic, ENT, CMF, spine and trauma. Founded in Munich in 1989, Brainlab has over 11,000 systems installed in about 100 countries.

Our other sponsors

Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery.

Stryker is one of the world’s leading medical technology companies and together with their customers,  are driven to make healthcare better. Stryker offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology, Craniomaxillofacial, neuro and spine products to help people lead more active and satisfying lives. Stryker products and services are available in over 100 countries around the world.

Specialised Therapeutics is an international biopharmaceutical company committed to commercialising new therapies and technologies for patients in Australia, New Zealand and across South East Asia.  In neurosurgery, we market the oral brain tumour visualisation drug GLIOLAN® (5-ALA) to fluoresce tumours during surgery.

The Carl Zeiss Group is a leading group of companies operating worldwide in the optical and opto-electronic industries.  Headquartered in Oberkochen, Germany, Carl Zeiss is represented in more than 30 countries around the world.
With innovations for ophthalmology, neurosurgery, spine, ENT and surgical oncology, the Medical Technology business group of ZEISS is contributing to progress in medicine. Our products and solutions aim to help physicians all over the world improve patient outcomes and their patients’ quality of life.
The KINEVO 900 Robotic Visualisation System from ZEISS will be at the Controversies in Neurosurgery 2018 meeting. We look forward to seeing you there.

Controversies in Neurosurgery 2018